Abbasi S, Dwaik H, Abbasi L, Al Hourani H. A pilot study of activity of pembrolizumab and low dose chemotherapy in relapsed/refractory T-cell lymphoma: Jordanian experience. Acta Biomed [Internet]. 2024 Oct. 29 [cited 2024 Nov. 17];95(5):e2024102. Available from: https://mattioli1885journals.com/index.php/actabiomedica/article/view/15559